Valeo Pharma Inc.
Valeo Pharma Inc.
Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory diseases, Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.
Valeo Pharma Inc. (VPH)
SEDAR Information
Company Info
Capitalization
News Releases
Bulletins
2022-0334 - Delist - Valeo Pharma Inc. (VPH, VPH.WT, VPH.WT.A)
le 25 mars/March 2022
At the request of the company the common shares and warrants of Valeo Pharma Inc. will be delisted at market close on March 28, 2022.
The securities will continue to trade on the Toronto Stock Exchange.
___________________________
À la demande de la société, les actions ordinaires et les bons de souscription de Valeo Pharma Inc. seront radiés à la clôture du marché le 28 mars 2022.
Les titres continueront d'être négociés à la Bourse de Toronto.